Literature DB >> 9132810

Treatment-related disseminated necrotizing leukoencephalopathy with characteristic contrast enhancement of the white matter.

S N Laxmi1, S Takahashi, K Matsumoto, S Higano, N Kurihara, M Imaizumi, K Abe, Y Itoyama, K Sakamoto.   

Abstract

This report describes unique contrast enhancement of the white matter on T1-weighted magnetic resonance images of two patients with disseminated necrotizing leukoencephalopathy, which developed from acute lymphoblastic leukemia treated with high-dose methotrexate. In both patients, the enhancement was more pronounced near the base of the brain than at the vertex. Necropsy of the first case revealed loss of myelination and necrosis of the white matter. Possible mechanisms causing such a leukoencephalopathy are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9132810

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  3 in total

1.  Leukoencephalopathy and disseminated necrotizing leukoencephalopathy following intrathecal methotrexate chemotherapy and radiation therapy for central nerve system lymphoma or leukemia.

Authors:  Ji Yeon Kim; Sung Tae Kim; Do-Hyun Nam; Jung-Il Lee; Kwan Park; Doo-Sik Kong
Journal:  J Korean Neurosurg Soc       Date:  2011-10-31

2.  Disseminated necrotizing leukoencephalopathy following chemoradiation therapy for acute lymphoblastic leukemia.

Authors:  Ajaya R Pande; Kumiko Ando; Reiichi Ishikura; Yuki Nagami; Masayo Ogawa; Norihiko Kamikonya; Yumi Kaneda; Takakuni Tanizawa; Norio Nakao
Journal:  Radiat Med       Date:  2006-08

3.  MRI in methotrexate-related leukoencephalopathy: Disseminated necrotising leukoencephalopathy in comparison with mild leukoencephalopathy.

Authors:  M Oka; S Terae; R Kobayashi; Y Sawamura; K Kudoh; K K Tha; M Yoshida; M Kaneda; Y Suzuki; K Miyasaka
Journal:  Neuroradiology       Date:  2003-05-22       Impact factor: 2.804

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.